Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Viridian Therapeutics Inc (VRDN)

Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Viridian Therapeutics Inc 221 CRESCENT STREET SUITE 401 WALTHAM MA 02453 USA

www.viridiantherapeutics.com P: 617-272-4600 F: 617-272-4601

Description:

Viridian Therapeutics Inc. is a biotechnology company advancing new treatments for patients suffering from serious diseases. The company's program includes VRDN-001, which is in clinical stage. Viridian Therapeutics Inc., formerly known as miRagen Therapeutics Inc., is based in BOULDER, Colo.

Key Statistics

Overview:

Market Capitalization, $K 817,867
Enterprise Value, $K 941,767
Shares Outstanding, K 62,768
Annual Sales, $ 310 K
Annual Net Income, $ -237,730 K
Last Quarter Sales, $ 70 K
Last Quarter Net Income, $ -66,860 K
EBIT, $ -254,450 K
EBITDA, $ -265,420 K
60-Month Beta 1.07
% of Insider Shareholders 1.43%
Float, K 61,870
% Float 98.57%
Short Volume Ratio 0.56

Growth:

1-Year Return -55.39%
3-Year Return -28.60%
5-Year Return -69.31%
5-Year Revenue Growth -96.31%
5-Year Earnings Growth 67.80%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.35 on 02/27/24
Latest Earnings Date 05/14/24
Earnings Per Share ttm -5.32
EPS Growth vs. Prev Qtr -23.85%
EPS Growth vs. Prev Year -19.47%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 11/13/20

VRDN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -121.80%
Return-on-Assets % -61.06%
Profit Margin % -76,687.09%
Debt/Equity 0.05
Price/Sales 2,848.55
Price/Cash Flow N/A
Price/Book 3.19
Book Value/Share 8.41
Interest Coverage -127.50
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar